Tomoko Kirihara

Pharmacologic Characterization of Omidenepag Isopropyl, a Novel Selective EP2 Receptor Agonist, as an Ocular Hypotensive Agent

Tomoko Kirihara, Takazumi Taniguchi, Kenzo Yamamura et al. · Investigative Ophthalmology & Visual Science · 2018 · 92 citations · Full text

Identification of a Selective, Non-Prostanoid EP2 Receptor Agonist for the Treatment of Glaucoma: Omidenepag and its Prodrug Omidenepag Isopropyl

Ryo Iwamura, Masayuki Tanaka, Eiji Okanari et al. · Journal of Medicinal Chemistry · 2018 · 51 citations · Full text

Medicinal Chemistry, Ocular Disease, Prodrug Omidenepag Isopropyl +11

Modulation of <i>mPer1</i> gene expression by anxiolytic drugs in mouse cerebellum

Masashi Akiyama, Tomoko Kirihara, Satomi Takahashi et al. · British Journal of Pharmacology · 1999 · 40 citations · Full text

Neurotransmitter, Social Sciences, Molecular Pharmacology +17

Potential Neuroprotective Effects of an LSD1 Inhibitor in Retinal Ganglion Cells via p38 MAPK Activity

Takayuki Tsutsumi, Keiichiro Iwao, Hideki Hayashi et al. · Investigative Ophthalmology & Visual Science · 2016 · 29 citations · Full text

Additive Intraocular Pressure-Lowering Effects of a Novel Selective EP2 Receptor Agonist, Omidenepag Isopropyl, Combined with Existing Antiglaucoma Agents in Conscious Ocular Normotensive Monkeys

Masahiro Fuwa, Atsushi Shimazaki, Noriko Odani‐Kawabata et al. · Journal of Ocular Pharmacology and Therapeutics · 2021 · 21 citations